Long-read sequencing-based diagnosis for complex genomic and DNA methylation changes
Active Project Grant Awarded Last action
- Award ID
- R41TR005388
- Recipient
-
D4Z4 Medicine, Inc. UEI PC6GTZFR4GY9
- Awarding agency
-
National Center for Advancing Translational Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $313,372
Award facts
- Assistance listing
- 93.350 National Center for Advancing Translational Sciences
- Completion date 62% complete
- Originally
- Place of performance
- Maryland, USA
Award details come from USAspending.gov.
Description
- Abstract
- Structural changes in the genome and alterations of DNA methylation contribute to many diseases. Properly assessing these types of changes can be challenging using current technologies. One of the focuses of D4Z4 medicine, INC., is to provide long-read sequencing-based assays that can be used to determine structural variations and DNA methylation in one assay. In this proposal, we focus on a molecular diagnostic assay for facioscapulohumeral muscular dystrophy (fshd). In addition to assay optimization, we will develop a user friendly and scalable data analysis tool, which will allow fast and accurate diagnostic report generation. In aim 1, we will standardize and validate the long-read sequencing assay. We will increase the capacity of the assay by adding additional target regions. We will also validate the assay using clinical samples. In aim 2, we will optimize a bioinformatics pipeline for analyzing long-read sequencing data containing D4Z4 repeat sequences and create a user-friendly interface. This approach developed here will provide a novel genetic diagnostic tool for fshd which does not have an effective diagnostic tool. In addition, the assay and analysis tool will be expanded to cover additional genes and diseases.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $313,372 |
Quick answers
Who received award R41TR005388?
R41TR005388 was awarded to D4Z4 Medicine, Inc. by National Center for Advancing Translational Sciences (National Institutes of Health) on August 7, 2025.
How much is award R41TR005388 worth?
$313,372 has been obligated on R41TR005388.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award